San Francisco, California (CA) Biological Research Companies

Featured companies
Barry Roth Consultant
745 Cole Street
San Francisco CA 941173911
(415) 994-4592

Consultancy specializing in biology of land snails and slugs
Bowling Vaccine & Pharmaceutical Inc
1631 45th Avenue
San Francisco CA 94122
(415) 731-8649
David Scalisi
435 Hayes St Te33
San Francisco CA 94102
(323) 230-3283
Not satisfied? Select a reasonRate this pageSend feedback

Or try our search form or quick navigation by category and location

Gary C Armitage Dds Ms
1952 16th Avenue
San Francisco CA 94116
(415) 476-8955
Global Blood Therapeutics Inc
55 Mission St.
San Francisco CA 94105
(415) 766-3600
Global Viral Forecasting Inc
1 Sutter St # 600
San Francisco CA 94104
(415) 398-4712

Global Viral Forecasting Inc is a privately held company in San Francisco, CA and is a Unknown business.
Howard Hughes Medical Inst
1550 4th St.
San Francisco CA 94158
(415) 476-6049
K Akassoglou
755 Tennessee St Apartment 9
San Francisco CA 94107
(415) 676-9257
Nanophotonic Biosciences Inc
1890 Sutter St Apartment 204
San Francisco CA 94115
Stemlifeline Inc
801 47th Avenue
San Francisco CA 94121
Sulfagen LLC
1591 Jackson St Apartment 3
San Francisco CA 94109
(412) 609-5115

Sulfagen LLC is a privately held company in San Francisco, CA and is a Single Location business.
Suzanne E Yin
1483 Sutter St Unit 1107
San Francisco CA 94109
(415) 885-0227
Whereorg has 12 results under Biological Research Companies in San Francisco.

Narrow down the browsing criteria below to see more companies.

Select a location for category Biological Research


Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020